Argenx
ARGX
$540.76
Share price
-0.26%
Change (1 day)
22.74%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Argenx (ARGX) - Net assets
Net assets on the balance sheet as of December 2024 : $5.49 Billion USD
According to Argenx
's latest financial reports the company has $5.49 Billion USD in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Argenx - Net assets on balance sheet (from 2021 to 2020)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $$5.49 B | 34.19% |
| 2023-12-31 | $$4.09 B | 45.63% |
| 2022-12-31 | $$2.81 B | 11.03% |
| 2021-12-31 | $$2.53 B | 23.08% |
| 2020-12-31 | $$2.05 B | 55.72% |
| 2019-12-31 | $$1.32 B | 87.68% |
| 2018-12-31 | $$0.70 B | 41.9% |
| 2017-12-31 | $$0.49 B | 608.23% |
| 2016-12-31 | $$70.1 M | 57.32% |
| 2015-12-31 | $$44.56 M | -39.83% |
| 2014-12-31 | $$74.06 M | 78.94% |
| 2013-12-31 | $$41.39 M | 87.92% |
| 2012-12-31 | $$22.02 M | -39.2% |
| 2011-12-31 | $$36.23 M | 166.19% |
| 2010-12-31 | $$13.61 M |